Haemolytic Anaemia

General Medicine

Anaemia from premature red-cell destruction (intra- or extravascular).

Etiology

  • Inherited: G6PD, hereditary spherocytosis, sickle, thalassaemia
  • Acquired: AIHA, drug-induced, MAHA, malaria, PNH

History taking

  • Jaundice, dark urine, gallstones
  • Family history, drugs, infection, transfusion

Examination

  • General: vitals, pallor, icterus, oedema, lymphadenopathy
  • Focused system examination
  • Look for red-flag findings

Red flags

  • Haemodynamic instability
  • Rapid deterioration
  • Severe pain or new neurological deficit

Differential diagnosis

  • See differentials section per chief complaint

Recommended investigations

  • Reticulocytes ↑, LDH ↑, haptoglobin ↓, unconjugated bilirubin ↑
  • Blood film, DAT (Coombs)
  • G6PD assay, Hb electrophoresis as indicated

Diagnosis

  • Clinical diagnosis supported by targeted investigations

Initial treatment / management

  • Identify and treat cause
  • Folic acid 5 mg OD
  • Steroids for warm AIHA

Follow-up advice

  • Review in 2–4 weeks or earlier if worsening
  • Monitor response to therapy and adverse effects

Patient counselling

  • Explain diagnosis and natural course in lay terms
  • Red-flag symptoms warranting urgent return
  • Adherence to medications and follow-up

Referral criteria

  • Refer if diagnostic uncertainty, complications, or failure of first-line therapy

Clinical pearls

  • Haptoglobin near 0 + raised LDH + raised retic = strong intravascular haemolysis

References

  • Harrison's Principles of Internal Medicine, 21e
  • NICE / WHO guidelines (current edition)

Educational outpatient guide — verify against local guidelines before clinical use.

WardRound

WardRound

Clinical Decisions in Seconds